hospitalization required Maintenance of Remission: Immunomodulators (azathioprine, 6-MP, methotrexate) for steroid-dependent or frequently-relapsing disease Biologic monotherapy or combination therapy (biologic + immunomodulator) for moderate-to-severe disease Step-up or top-down approach based on disease severity, patient risk factors, and prior therapy Biologic Therapy Targets: TNF-: Infliximab (IV), adalimumab (SC), certolizumab pegol (SC) IL-12/23: Ustekinumab (IV induction, SC maintenance) Integrin: Vedolizumab (IV) IL-23: Risankizumab (IV induction, SC maintenance) JAK inhibition: Upadacitinib (oral) Surgical Management Surgery is indicated in approximately 7080% of patients with Crohns disease over their lifetime, per StatPearls
avoid stomach sleeping which hyperextends the neck
Endocr J 35: 135-142, 1988
We show that the heterogeneity in mitochondrial function and signalling observed across CRC samples could explain, and be used to predict, poor clinical responses in patients with locally advanced CRC
The verdict: GHK-Cu for skin, collagen peptides for hair/nails Choose GHK-Cu if: Skin anti-aging is primary goal Want injectable or topical option Focused on wrinkles and firmness Choose collagen peptides if: Want overall beauty benefits Prefer oral supplementation Hair and nails are priority Best peptide combinations and stacks Combining peptides provides synergistic benefits
You must get it through your diet or through supplementation
